Squamous cell carcinoma of the lung screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 10: Line 10:


'''Guidelines'''
'''Guidelines'''
* According to the clinical practice guideline by the U.S. Preventive Services Task Force ([[USPSTF]]), screening for lung cancer by low-dose computed tomography (LDCT) is recommended every year among smokers and former smokers who are between 55 to 80 years old and who have smoked 30 pack-years or more and either continue to smoke or have quit within the past 15 years (grade B recommendation).<ref name="abc">Lung Cancer Screening. U.S. Preventive Services Task Force 2015. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening Accessed on December 20, 2015</ref><ref name=“lung screen">Lung Cancer: Screening  http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening. Accessed on February 3, 2016 <nowiki></ref><ref name="“JAMA”">Davis AM, Cifu AS. Lung Cancer Screening. JAMA. 2014;312(12):1248-1249. doi:10.1001/jama.2014.12272.</ref><ref> name=“ludng">https://www.cancer.gov/types/lung/research/nlst https://www.cancer.gov/types/lung/research/NLSTstudyGuidePatientsPhysicians.pdf National_Lung_Screening_Trial Accessed on February 4,2016</ref>
* According to the clinical practice guideline by the U.S. Preventive Services Task Force ([[USPSTF]]), screening for lung cancer by low-dose computed tomography (LDCT) is recommended every year among smokers and former smokers who are between 55 to 80 years old and who have smoked 30 pack-years or more and either continue to smoke or have quit within the past 15 years (grade B recommendation).<ref name="abc">Lung Cancer Screening. U.S. Preventive Services Task Force 2015. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening Accessed on December 20, 2015</ref><ref name="“lung" screen"="">Lung Cancer: Screening  http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening. Accessed on February 3, 2016 &lt;nowiki&gt;&lt;nowiki&gt;</ref><ref name="“JAMA”">Davis AM, Cifu AS. Lung Cancer Screening. JAMA. 2014;312(12):1248-1249. doi:10.1001/jama.2014.12272.</ref><ref name="“ludng&quot;">National Lung Screening Trial.National_Lung_Screening_Trial Accessed on February 4,2016 https://www.cancer.gov/types/lung/research/nlst
https://www.cancer.gov/types/lung/research/NLSTstudyGuidePatientsPhysicians.pdf</ref>


* According to the [[American College of Chest Physicians]] (CHEST) in 2013, screening for lung cancer by low-dose CT (LDCT) is recommended every year among smokers and former smokers who are aged between 55 and 74 years and who have smoked for 30 pack-years or more and either continue to smoke or have quit within the past 15 years.<ref name="pmid23649455">{{cite journal| author=Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB| title=Screening for Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | journal=Chest | year= 2013 | volume= 143 | issue= 5 Suppl | pages= e78S-92S | pmid=23649455 | doi=10.1378/chest.12-2350 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23649455  }} [http://general-medicine.jwatch.org/cgi/content/full/2013/522/2 Summary in JournalWatch]</ref>
* According to the [[American College of Chest Physicians]] (CHEST) in 2013, screening for lung cancer by low-dose CT (LDCT) is recommended every year among smokers and former smokers who are aged between 55 and 74 years and who have smoked for 30 pack-years or more and either continue to smoke or have quit within the past 15 years.<ref name="pmid23649455">{{cite journal| author=Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB| title=Screening for Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | journal=Chest | year= 2013 | volume= 143 | issue= 5 Suppl | pages= e78S-92S | pmid=23649455 | doi=10.1378/chest.12-2350 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23649455  }} [http://general-medicine.jwatch.org/cgi/content/full/2013/522/2 Summary in JournalWatch]</ref>
Line 18: Line 19:
'''Strategies'''
'''Strategies'''


* Low-dose helical computed tomography<ref name="lungscreen">Lung Cancer Screening. National Cancer Institute 2015. http://www.cancer.gov/types/lung/hp/lung-screening-pdq Accessed on December 20, 2015</ref>
* Low-dose helical [[computed tomography]]:<ref name="lungscreen">Lung Cancer Screening. National Cancer Institute 2015. http://www.cancer.gov/types/lung/hp/lung-screening-pdq Accessed on December 20, 2015</ref>
:* Benefits
:* Benefits
::* There is evidence that screening persons aged 55 to 74 years who have cigarette smoking histories of 30 or more pack-years and who, if they are former smokers, have quit within the last 15 years reduces lung cancer mortality by 20% and all-cause mortality by 6.7%.
::* There is evidence that screening persons aged 55 to 74 years who have [[cigarette]] smoking histories of 30 or more pack-years and who, if they are former smokers, have quit within the last 15 years reduces lung cancer mortality by 20% and all-cause mortality by 6.7%.


:* Harms
:* Harms
Line 26: Line 27:
::* False-positive exams may result in unnecessary invasive diagnostic procedures.
::* False-positive exams may result in unnecessary invasive diagnostic procedures.


* Chest x-ray and/or sputum cytology<ref name="JAMA">Davis AM, Cifu AS. Lung Cancer Screening. JAMA. 2014;312(12):1248-1249. doi:10.1001/jama.2014.12272.</ref>
* Chest x-ray and/or sputum cytology:<ref name="pmid24037918">{{cite journal |vauthors=Pinsky PF, Church TR, Izmirlian G, Kramer BS |title=The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology |journal=Cancer |volume=119 |issue=22 |pages=3976–83 |date=November 2013 |pmid=24037918 |pmc=3936005 |doi=10.1002/cncr.28326 |url=}}</ref><ref name="JAMA">Davis AM, Cifu AS. Lung Cancer Screening. JAMA. 2014;312(12):1248-1249. doi:10.1001/jama.2014.12272.</ref><ref name="pmid21714641">{{cite journal |vauthors=Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD |title=Reduced lung-cancer mortality with low-dose computed tomographic screening |journal=N. Engl. J. Med. |volume=365 |issue=5 |pages=395–409 |date=August 2011 |pmid=21714641 |pmc=4356534 |doi=10.1056/NEJMoa1102873 |url=}}</ref>
:*Benefits
:*Benefits
::*Screening with chest x-ray and/or sputum cytology does not reduce mortality from lung cancer in the general population or in ever-smokers.
::*Screening with [[Chest X-ray|chest x-ray]] and/or sputum cytology does not reduce [[mortality]] from [[lung cancer]] in the general population or in ever-smokers.


:* Harms
:* Harms
::* False positive exams
::* False positive exams
::* The majority of all positive chest x-ray screening exams do not result in a true positive diagnosis of lung cancer.  
::* The majority of all positive [[Chest X-ray|chest x-ray]] screening exams do not result in a true positive diagnosis of [[lung cancer]].  
::* False-positive exams result in unnecessary invasive diagnostic procedures.
::* False-positive exams result in unnecessary [[invasive]] diagnostic procedures.


'''Over-diagnosis'''
'''Over-diagnosis'''


* Based on current evidence, the majority of non-small cell lung cancers detected by screening chest x-ray and/or sputum cytology appear to represent over-diagnosed cancer.<ref name="JAMA">Davis AM, Cifu AS. Lung Cancer Screening. JAMA. 2014;312(12):1248-1249. doi:10.1001/jama.2014.12272.</ref>
* Based on current evidence, the majority of non-small cell lung cancers detected by screening [[Chest X-ray|chest x-ray]] and/or sputum cytology appear to represent over-diagnosed cancer.<ref name="JAMA">Davis AM, Cifu AS. Lung Cancer Screening. JAMA. 2014;312(12):1248-1249. doi:10.1001/jama.2014.12272.</ref>


*The magnitude of over-diagnosis appears to be between 5% and 25%.  
*The magnitude of over-diagnosis appears to be between 5% and 25%.  
*These cancers result in unnecessary diagnostic procedures and also lead to unnecessary treatment.  
*These cancers result in unnecessary diagnostic procedures and also lead to unnecessary treatment.  
*Harms of diagnostic procedures and treatment occur most frequently among long-term and/or heavy smokers because of smoking-associated co-morbidities that increase risk propagation.
*Harms of diagnostic procedures and treatment occur most frequently among long-term and/or heavy smokers because of smoking-associated comorbidities that increase risk propagation.


==References==
==References==

Latest revision as of 20:27, 17 October 2019

Squamous Cell Carcinoma of the Lung Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Squamous Cell Carcinoma of the Lung from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Squamous cell carcinoma of the lung screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Squamous cell carcinoma of the lung screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Squamous cell carcinoma of the lung screening

CDC on Squamous cell carcinoma of the lung screening

Squamous cell carcinoma of the lung screening in the news

Blogs on Squamous cell carcinoma of the lung screening

Directions to Hospitals Treating Squamous cell carcinoma of the lung

Risk calculators and risk factors for Squamous cell carcinoma of the lung screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2] Maria Fernanda Villarreal, M.D. [3]

Overview

According to the U.S. Preventive Services Task Force (USPSTF), screening for lung cancer by low-dose computed tomography (LDCT) is recommended every year among smokers who are between 55 to 80 years old and who have history of smoke 30 pack-years or more and either continue to smoke or have quit within the past 15 years (grade B recommendation).

Screening

Guidelines

  • According to the clinical practice guideline by the U.S. Preventive Services Task Force (USPSTF), screening for lung cancer by low-dose computed tomography (LDCT) is recommended every year among smokers and former smokers who are between 55 to 80 years old and who have smoked 30 pack-years or more and either continue to smoke or have quit within the past 15 years (grade B recommendation).[1][2][3][4]
  • According to the American College of Chest Physicians (CHEST) in 2013, screening for lung cancer by low-dose CT (LDCT) is recommended every year among smokers and former smokers who are aged between 55 and 74 years and who have smoked for 30 pack-years or more and either continue to smoke or have quit within the past 15 years.[5]
  • To view all the screening guidelines recommendations for squamous cell lung carcinoma, click here

Strategies

  • Benefits
  • There is evidence that screening persons aged 55 to 74 years who have cigarette smoking histories of 30 or more pack-years and who, if they are former smokers, have quit within the last 15 years reduces lung cancer mortality by 20% and all-cause mortality by 6.7%.
  • Harms
  • The majority of of all positive low-dose helical computed tomography screening exams do not result in a lung cancer diagnosis.
  • False-positive exams may result in unnecessary invasive diagnostic procedures.
  • Benefits
  • Harms
  • False positive exams
  • The majority of all positive chest x-ray screening exams do not result in a true positive diagnosis of lung cancer.
  • False-positive exams result in unnecessary invasive diagnostic procedures.

Over-diagnosis

  • Based on current evidence, the majority of non-small cell lung cancers detected by screening chest x-ray and/or sputum cytology appear to represent over-diagnosed cancer.[8]
  • The magnitude of over-diagnosis appears to be between 5% and 25%.
  • These cancers result in unnecessary diagnostic procedures and also lead to unnecessary treatment.
  • Harms of diagnostic procedures and treatment occur most frequently among long-term and/or heavy smokers because of smoking-associated comorbidities that increase risk propagation.

References

  1. Lung Cancer Screening. U.S. Preventive Services Task Force 2015. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening Accessed on December 20, 2015
  2. Lung Cancer: Screening http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening. Accessed on February 3, 2016 <nowiki><nowiki>
  3. Davis AM, Cifu AS. Lung Cancer Screening. JAMA. 2014;312(12):1248-1249. doi:10.1001/jama.2014.12272.
  4. National Lung Screening Trial.National_Lung_Screening_Trial Accessed on February 4,2016 https://www.cancer.gov/types/lung/research/nlst https://www.cancer.gov/types/lung/research/NLSTstudyGuidePatientsPhysicians.pdf
  5. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB (2013). "Screening for Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines". Chest. 143 (5 Suppl): e78S–92S. doi:10.1378/chest.12-2350. PMID 23649455. Summary in JournalWatch
  6. Lung Cancer Screening. National Cancer Institute 2015. http://www.cancer.gov/types/lung/hp/lung-screening-pdq Accessed on December 20, 2015
  7. Pinsky PF, Church TR, Izmirlian G, Kramer BS (November 2013). "The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology". Cancer. 119 (22): 3976–83. doi:10.1002/cncr.28326. PMC 3936005. PMID 24037918.
  8. 8.0 8.1 Davis AM, Cifu AS. Lung Cancer Screening. JAMA. 2014;312(12):1248-1249. doi:10.1001/jama.2014.12272.
  9. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD (August 2011). "Reduced lung-cancer mortality with low-dose computed tomographic screening". N. Engl. J. Med. 365 (5): 395–409. doi:10.1056/NEJMoa1102873. PMC 4356534. PMID 21714641.


Template:WikiDoc Sources